First human in gene-editing trial infused with CRISPR to 'cure' rare blood disorder Daily Mail
The US and Swiss companies behind the venture claim to be the first ever to use CRISPR on a human, disregarding the use of it on cancer patients in China.
(CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment